(SPRY) Silverback - Performance 81.7% in 12m
SPRY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-9.00%
#37 in Peer-Group
Rel. Strength
91.78%
#634 in Stock-Universe
Total Return 12m
81.74%
#16 in Peer-Group
Total Return 5y
-33.92%
#47 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 18.20 USD |
| 52 Week Low | 9.09 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 58.23 |
| Buy/Sell Signal +-5 | -0.50 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SPRY (81.7%) vs XBI (-6.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.94% | 73.2% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.16% | -5.32% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.99% | -0.49% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.6% | 32.8% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.29% | -6.6% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
17.1% | 57.4% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-3.2% | 58.3% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
5.64% | 38.5% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: SPRY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SPRY
| Total Return (including Dividends) | SPRY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 13.70% | 3.53% | 5.22% |
| 3 Months | 23.28% | 9.10% | 16.86% |
| 12 Months | 81.74% | -6.17% | 14.81% |
| 5 Years | -33.92% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | SPRY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 87.1% | 4.4% | 81% |
| 3 Months | 66% | 78.8% | 96.9% |
| 12 Months | 34.7% | -85.8% | 44.9% |
| 5 Years | -3.1% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.50 | 9.82% | 8.06% |
| 3 Month | %th62.50 | 13.01% | 5.49% |
| 12 Month | %th92.00 | 93.68% | 58.29% |
| 5 Years | %th79.00 | 5.24% | -63.46% |
FAQs
Does Silverback (SPRY) outperform the market?
Yes,
over the last 12 months SPRY made 81.74%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%.
Over the last 3 months SPRY made 23.28%, while XBI made 9.10%.
Performance Comparison SPRY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SPRY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -10.8% | 8.5% | 41.4% | 67% |
| US NASDAQ 100 | QQQ | -10.5% | 8.1% | 40.1% | 68% |
| German DAX 40 | DAX | -9.8% | 14.4% | 27.9% | 52% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -9.1% | 9.5% | 38.5% | 63% |
| Hongkong Hang Seng | HSI | -9.9% | 7.4% | 23% | 46% |
| India NIFTY 50 | INDA | -8.8% | 10.3% | 43.1% | 82% |
| Brasil Bovespa | EWZ | -12.8% | 5.5% | 14.6% | 70% |
SPRY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -10.1% | 7.1% | 36.7% | 55% |
| Consumer Discretionary | XLY | -11.5% | 10.8% | 49.2% | 63% |
| Consumer Staples | XLP | -11.1% | 13.8% | 41.4% | 72% |
| Energy | XLE | -10.1% | 8.7% | 46.5% | 84% |
| Financial | XLF | -11.3% | 9.2% | 37.4% | 52% |
| Health Care | XLV | -9.6% | 11.4% | 49.3% | 86% |
| Industrial | XLI | -11.4% | 9.4% | 34.4% | 57% |
| Materials | XLB | -12.7% | 9% | 36.7% | 76% |
| Real Estate | XLRE | -10.7% | 12.4% | 43.7% | 69% |
| Technology | XLK | -11% | 4.9% | 38.3% | 70% |
| Utilities | XLU | -9.5% | 13.7% | 40% | 59% |
| Aerospace & Defense | XAR | -9.6% | 6.1% | 24.2% | 33% |
| Biotech | XBI | -10.5% | 10.2% | 55.4% | 88% |
| Homebuilder | XHB | -13.8% | 5.2% | 49.2% | 77% |
| Retail | XRT | -13.9% | 9.4% | 45.9% | 70% |
SPRY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -10.8% | 6.12% | 51.1% | 89% |
| Natural Gas | UNG | -6% | 23.8% | 49.8% | 88% |
| Gold | GLD | -8.8% | 14.3% | 21.5% | 41% |
| Silver | SLV | -9.1% | 7.1% | 23.4% | 61% |
| Copper | CPER | -9.3% | 8.7% | 22.7% | 68% |
SPRY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -7.9% | 11% | 45.8% | 83% |
| iShares High Yield Corp. Bond | HYG | -9.1% | 11.9% | 42.9% | 71% |